Plotkin Financial Advisors’s CEL-SCI Corp CVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,067
Closed -$21.2K 95
2025
Q1
$21.2K Hold
3,067
0.01% 92
2024
Q4
$36.8K Hold
3,067
0.02% 91
2024
Q3
$97.5K Hold
3,067
0.06% 90
2024
Q2
$107K Hold
3,067
0.07% 86
2024
Q1
$176K Hold
3,067
0.12% 89
2023
Q4
$250K Hold
3,067
0.19% 68
2023
Q3
$115K Hold
3,067
0.1% 75
2023
Q2
$222K Hold
3,067
0.18% 69
2023
Q1
$213K Hold
3,067
0.2% 65
2022
Q4
$216K Hold
3,067
0.22% 64
2022
Q3
$284K Buy
+3,067
New +$370K 0.29% 53

Other funds holding CVM

Plotkin Financial Advisors's CVM Position: Q2 2025 in Review

Plotkin Financial Advisors sold out of CEL-SCI Corp (CVM) in Q2 2025, closing a stake of 3,067 shares — an estimated $21.2K sold.

Plotkin Financial Advisors first reported a position in CVM in Q3 2022 and held it in 11 quarters. The position peaked at $284K in Q3 2022. 28 funds tracked by Wall St. Rank hold CVM as of Q2 2025.

  • Plotkin Financial Advisors reported no remaining CEL-SCI Corp position as of Q2 2025 after selling out during the quarter.
  • Plotkin Financial Advisors sold 3,067 CEL-SCI Corp shares in Q2 2025, an estimated $21.2K.
  • Plotkin Financial Advisors first reported a position in CEL-SCI Corp in Q3 2022 and held it in 11 quarters.
  • Plotkin Financial Advisors's CEL-SCI Corp position peaked at $284K in Q3 2022.
  • 28 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q2 2025.

Based on Plotkin Financial Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.